Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.538 EUR | +0.40% |
|
+3.49% | -2.91% |
Chart calendar Clinuvel Pharmaceuticals Limited
Upcoming events on Clinuvel Pharmaceuticals Limited
Past events on Clinuvel Pharmaceuticals Limited
01/05/2024 00:00 | Capital Markets Day |
22/02/2024 07:00 | Q2 2024 Earnings Call |
21/02/2024 22:48 | Q2 2024 Earnings Release |
20/11/2023 | Roadshow |
19/11/2023 | Roadshow |
14/11/2023 | Bell Potter Healthcare Conference |
30/10/2023 23:00 | Annual General Meeting |
17/10/2023 | J P Morgan Bio Tech Conference |
04/09/2023 | Détachement de for final dividend |
03/09/2023 | Roadshow |
30/08/2023 | Roadshow |
29/08/2023 | Roadshow - Wilsons Advisory |
29/08/2023 09:00 | Q4 2023 Earnings Call |
29/08/2023 01:36 | Q4 2023 Earnings Release |
22/02/2023 22:41 | Interim 2023 Earnings Release |
30/01/2023 22:32 | December 2022 Sales and Revenue Release - Activities Report |
14/11/2022 | Jefferies London Healthcare Conference |
30/10/2022 | September 2022 Sales and Revenue Release |
26/10/2022 00:00 | Annual General Meeting |
11/09/2022 | H.C. Wainwright Global Investment Conference |
Past dividends on Clinuvel Pharmaceuticals Limited
04/09/2023 | Annual 0.05 AUD |
05/09/2022 | Annual 0.04 AUD |
01/09/2021 | Annual 0.025 AUD |
02/09/2020 | Annual 0.025 AUD |
03/09/2019 | Annual 0.025 AUD |
20/09/2018 | Final Payment 0.02 AUD |
Annual results
Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 31,0 31,0 0.15% | 32,6 34,0 -4.22% | 48,0 42,1 14% | 65,7 67,4 -2.5% | 78,3 80,3 -2.41% | 88,3 |
EBITDA Million AUD | Released Forecast Spread | 17,6 16,5 6.92% | 13,0 12,2 6.78% | 26,1 21,0 24.07% | 37,4 30,1 24.37% | 37,2 39,7 -6.37% | 43,3 |
EBIT Million AUD | Released Forecast Spread | 17,6 16,4 7.01% | 12,6 11,9 5.88% | 25,2 20,7 22.12% | 36,7 29,2 25.5% | 36,4 38,9 -6.31% | 42,3 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | 18,1 16,9 7.19% | 13,1 12,7 3.43% | 25,7 23,8 8.04% | 34,3 29,5 16.34% | 45,6 42,6 7.12% | 50,7 |
Net income Million AUD | Released Forecast Spread | 18,1 16,9 7.3% | 16,6 12,7 31.08% | 24,7 19,5 26.98% | 20,9 20,3 2.82% | 30,6 29,8 2.59% | 34,3 |
EPS AUD | Released Forecast Spread | 0,37 0,35 4.57% | 0,33 0,26 26.92% | 0,48 0,39 25.42% | 0,40 0,40 -0.19% | 0,59 0,59 1.02% | 0,68 |
Announcement Date | 28/08/19 | 26/08/20 | 26/08/21 | 30/08/22 | 29/08/23 | - |
Quarterly results
Fiscal Period | June | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 13,6 20,3 -32.84% | 34,3 28,1 22.22% | 41,1 35,6 15.42% | 49,0 46,3 5.76% | 32,3 34,4 -6.32% | 53,8 | ||
EBITDA Million AUD | Released Forecast Spread | 5,61 10,5 -46.54% | 20,5 20,2 1.41% | 9,85 10,0 -1.53% | 27,7 20,8 33.24% | 14,9 19,2 -22.36% | 22,3 24,6 -9.36% | 13,7 15,2 -9.62% | 33,2 |
EBIT Million AUD | Released Forecast Spread | 5,61 10,3 -45.5% | 19,6 19,7 -0.38% | 9,45 9,70 -2.53% | 27,3 20,0 36.75% | 14,5 18,9 -23.12% | 21,9 24,1 -9.19% | 13,2 15,5 -15.08% | 33,3 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | 5,81 11,0 -47.17% | 19,9 20,7 -3.86% | 8,73 10,0 -12.74% | 25,6 20,1 27.34% | 14,6 19,1 -23.56% | 31,0 25,5 21.49% | 14,8 17,7 -16.35% | 37,3 |
Net income Million AUD | Released Forecast Spread | 6,49 11,0 -41.02% | 18,2 12,1 50.75% | 5,87 11,5 -48.95% | 15,0 13,4 12% | 11,4 16,1 -29.27% | 19,2 19,1 0.61% | 10,9 14,8 -26.11% | 25,6 |
EPS AUD | Released Forecast Spread | 0,13 0,22 -41.47% | 0,36 0,24 49.37% | 0,11 0,23 -49.33% | 0,29 0,26 9.89% | 0,22 0,31 -29.49% | 0,37 0,37 0.82% | 0,21 0,28 -22.91% | 0,49 |
Announcement Date | 23/02/21 | 26/08/21 | 22/02/22 | 30/08/22 | 23/02/23 | 29/08/23 | 21/02/24 | - |
11/07/2024 07:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
15/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
22/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 07:00 | BIOGAIA AB: Q2 2024 Earnings Release |
23/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
25/07/2024 06:00 | UCB: Q2 2024 Earnings Release |
25/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
29/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Clinuvel Pharmaceuticals Limited
23/05/2024 10:43 | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
14/05/2024 16:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
13/05/2024 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
09/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
09/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
09/05/2024 21:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
09/05/2024 21:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
09/05/2024 07:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
08/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
08/05/2024 21:16 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CUV Stock
- UR9 Stock
- Calendar Clinuvel Pharmaceuticals Limited